Care Ratings Share Price
Sector: Business Services
1771.20 +17.25 (0.98%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1761.30
Today’s High
1799.00
52 Week Low
922.00
52 Week High
1964.80
1766.40 +11.60 (0.66%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1762.00
Today’s High
1797.40
52 Week Low
921.80
52 Week High
1964.00
Key Metrics
- Market Cap (In Cr) 5288.83
- Beta 0.75
- Div. Yield (%) 1.03
- P/B 6.51
- TTM P/E 24.1
- Peg Ratio 1.77
- Sector P/E 26.72
- D/E 0
- Open Price 1799
- Prev Close 1753.95
Care Ratings Analysis
Price Analysis
-
1 Week-5.53%
-
3 Months59.75%
-
6 Month32.4%
-
YTD27.19%
-
1 Year67.02%
Risk Meter
- 46% Low risk
- 46% Moderate risk
- 46% Balanced Risk
- 46% High risk
- 46% Extreme risk
Care Ratings News
India’s household savings show a sustained fall; liabilities rise: CareEdge
3 min read . 15 Jun 2025Q4 results today: Tata Steel, JM Financial, Raymond, Bajaj Electricals on May 12
1 min read . 12 May 2025Care Ratings Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 402.32
- Selling/ General/ Admin Expenses Total
- 241.28
- Depreciation/ Amortization
- 11.72
- Other Operating Expenses Total
- 4.42
- Total Operating Expense
- 258.7
- Operating Income
- 143.62
- Net Income Before Taxes
- 192.27
- Net Income
- 137.24
- Diluted Normalized EPS
- 45.69
- Period
- 2025
- Total Assets
- 957.74
- Total Liabilities
- 151.48
- Total Equity
- 806.27
- Tangible Book Valueper Share Common Eq
- 262.49
- Period
- 2025
- Cashfrom Operating Activities
- 122.95
- Cashfrom Investing Activities
- -58.43
- Cashfrom Financing Activities
- -54
- Net Changein Cash
- 10.53
- Period
- 2024
- Total Revenue
- 331.69
- Selling/ General/ Admin Expenses Total
- 214.46
- Depreciation/ Amortization
- 10.48
- Other Operating Expenses Total
- 3.92
- Total Operating Expense
- 230.03
- Operating Income
- 101.66
- Net Income Before Taxes
- 146.63
- Net Income
- 100.52
- Diluted Normalized EPS
- 33.67
- Period
- 2024
- Total Assets
- 841.76
- Total Liabilities
- 124.63
- Total Equity
- 717.13
- Tangible Book Valueper Share Common Eq
- 234.55
- Period
- 2024
- Cashfrom Operating Activities
- 90.88
- Cashfrom Investing Activities
- -39.07
- Cashfrom Financing Activities
- -62.96
- Net Changein Cash
- -11.14
- Period
- 2023
- Total Revenue
- 278.99
- Selling/ General/ Admin Expenses Total
- 170.07
- Depreciation/ Amortization
- 10.53
- Other Operating Expenses Total
- 2.72
- Total Operating Expense
- 190.18
- Operating Income
- 88.81
- Net Income Before Taxes
- 125.75
- Net Income
- 83.53
- Diluted Normalized EPS
- 29.47
- Period
- 2023
- Total Assets
- 769.62
- Total Liabilities
- 97.41
- Total Equity
- 672.21
- Tangible Book Valueper Share Common Eq
- 221.56
- Period
- 2023
- Cashfrom Operating Activities
- 82.24
- Cashfrom Investing Activities
- 12.88
- Cashfrom Financing Activities
- -63.33
- Net Changein Cash
- 31.79
- Period
- 2022
- Total Revenue
- 247.63
- Selling/ General/ Admin Expenses Total
- 165.71
- Depreciation/ Amortization
- 7.71
- Other Operating Expenses Total
- 1.3
- Total Operating Expense
- 175.73
- Operating Income
- 71.9
- Net Income Before Taxes
- 98.63
- Net Income
- 75.11
- Diluted Normalized EPS
- 25.37
- Period
- 2022
- Total Assets
- 727.41
- Total Liabilities
- 79.91
- Total Equity
- 647.49
- Tangible Book Valueper Share Common Eq
- 212.83
- Period
- 2022
- Cashfrom Operating Activities
- 68
- Cashfrom Investing Activities
- -27.32
- Cashfrom Financing Activities
- -35.14
- Net Changein Cash
- 5.55
- Period
- 2021
- Total Revenue
- 248.45
- Selling/ General/ Admin Expenses Total
- 149.81
- Depreciation/ Amortization
- 7.8
- Other Operating Expenses Total
- 1.93
- Total Operating Expense
- 160.48
- Operating Income
- 87.97
- Net Income Before Taxes
- 118.65
- Net Income
- 89.52
- Diluted Normalized EPS
- 32.1
- Period
- 2021
- Total Assets
- 671.77
- Total Liabilities
- 82.95
- Total Equity
- 588.82
- Tangible Book Valueper Share Common Eq
- 195.98
- Period
- 2021
- Cashfrom Operating Activities
- 86.17
- Cashfrom Investing Activities
- -38.02
- Cashfrom Financing Activities
- -43.36
- Net Changein Cash
- 4.79
- Period
- 2020
- Total Revenue
- 243.64
- Selling/ General/ Admin Expenses Total
- 158.62
- Depreciation/ Amortization
- 7.77
- Other Operating Expenses Total
- 2.37
- Total Operating Expense
- 170.09
- Operating Income
- 73.55
- Net Income Before Taxes
- 104.09
- Net Income
- 82.37
- Diluted Normalized EPS
- 29.86
- Period
- 2020
- Total Assets
- 619.02
- Total Liabilities
- 85.76
- Total Equity
- 533.26
- Tangible Book Valueper Share Common Eq
- 177.84
- Period
- 2020
- Cashfrom Operating Activities
- 67.4
- Cashfrom Investing Activities
- 26.73
- Cashfrom Financing Activities
- -106.96
- Net Changein Cash
- -12.83
- Period
- 2019
- Total Revenue
- 318.97
- Selling/ General/ Admin Expenses Total
- 139.98
- Depreciation/ Amortization
- 3.33
- Other Operating Expenses Total
- 3.07
- Total Operating Expense
- 133.36
- Operating Income
- 185.61
- Net Income Before Taxes
- 201.73
- Net Income
- 137.47
- Diluted Normalized EPS
- 43.35
- Period
- 2019
- Total Assets
- 615.13
- Total Liabilities
- 65.16
- Total Equity
- 549.97
- Tangible Book Valueper Share Common Eq
- 183.48
- Period
- 2019
- Cashfrom Operating Activities
- 108.56
- Cashfrom Investing Activities
- 82.62
- Cashfrom Financing Activities
- -195.35
- Net Changein Cash
- -4.17
- Period
- 2025-03-31
- Total Revenue
- 109.65
- Selling/ General/ Admin Expenses Total
- 47.12
- Depreciation/ Amortization
- 3.06
- Other Operating Expenses Total
- 15.16
- Total Operating Expense
- 65.34
- Operating Income
- 44.31
- Net Income Before Taxes
- 58.89
- Net Income
- 42.61
- Diluted Normalized EPS
- 14.17
- Period
- 2025-03-31
- Total Assets
- 957.74
- Total Liabilities
- 151.48
- Total Equity
- 806.27
- Tangible Book Valueper Share Common Eq
- 262.49
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 122.95
- Cashfrom Investing Activities
- -58.43
- Cashfrom Financing Activities
- -54
- Net Changein Cash
- 10.53
- Period
- 2024-12-31
- Total Revenue
- 96.38
- Selling/ General/ Admin Expenses Total
- 50.33
- Depreciation/ Amortization
- 3
- Other Operating Expenses Total
- 15.62
- Total Operating Expense
- 68.95
- Operating Income
- 27.43
- Net Income Before Taxes
- 38.72
- Net Income
- 27.8
- Diluted Normalized EPS
- 9.24
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 117.37
- Selling/ General/ Admin Expenses Total
- 45.73
- Depreciation/ Amortization
- 2.85
- Other Operating Expenses Total
- 15.92
- Total Operating Expense
- 64.5
- Operating Income
- 52.87
- Net Income Before Taxes
- 64.23
- Net Income
- 46.09
- Diluted Normalized EPS
- 15.36
- Period
- 2024-09-30
- Total Assets
- 893.68
- Total Liabilities
- 140.01
- Total Equity
- 753.67
- Tangible Book Valueper Share Common Eq
- 246.41
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 8.03
- Cashfrom Investing Activities
- 49.7
- Cashfrom Financing Activities
- -29.36
- Net Changein Cash
- 28.37
- Period
- 2024-06-30
- Total Revenue
- 78.92
- Selling/ General/ Admin Expenses Total
- 45.74
- Depreciation/ Amortization
- 2.8
- Other Operating Expenses Total
- 11.35
- Total Operating Expense
- 59.9
- Operating Income
- 19.02
- Net Income Before Taxes
- 30.43
- Net Income
- 20.73
- Diluted Normalized EPS
- 6.91
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 90.15
- Selling/ General/ Admin Expenses Total
- 43.24
- Depreciation/ Amortization
- 2.67
- Other Operating Expenses Total
- 17.87
- Total Operating Expense
- 63.79
- Operating Income
- 26.36
- Net Income Before Taxes
- 36.19
- Net Income
- 24.08
- Diluted Normalized EPS
- 8.03
- Period
- 2024-03-31
- Total Assets
- 841.76
- Total Liabilities
- 124.63
- Total Equity
- 717.13
- Tangible Book Valueper Share Common Eq
- 234.55
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 90.88
- Cashfrom Investing Activities
- -39.07
- Cashfrom Financing Activities
- -62.96
- Net Changein Cash
- -11.14
- Period
- 2023-12-31
- Total Revenue
- 78.68
- Selling/ General/ Admin Expenses Total
- 42.51
- Depreciation/ Amortization
- 2.6
- Other Operating Expenses Total
- 12.82
- Total Operating Expense
- 57.93
- Operating Income
- 20.75
- Net Income Before Taxes
- 33.96
- Net Income
- 23.46
- Diluted Normalized EPS
- 7.85
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Care Ratings Technical
Moving Average
SMA
- 5 Day1836.6
- 10 Day1858.66
- 20 Day1818.57
- 50 Day1545.6
- 100 Day1358.1
- 300 Day1314.6
Care Ratings Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Icra
- 6692.75
- 11.9
- 0.18
- 7700
- 5085.9
- 6475.25
- Axiscades Technologies
- 1425.3
- 63
- 4.62
- 1479
- 421.05
- 6024.03
- Care Ratings
- 1771.2
- 17.25
- 0.98
- 1964.8
- 922
- 5288.83
- Sun Pharma Advanced Research Com
- 161.6
- 2
- 1.25
- 257.7
- 109.2
- 5244.27
- Quess Corp
- 305.45
- 5.8
- 1.94
- 427.49
- 275.55
- 4549.66
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Icra
- 38.15
- 6.15
- 14.76
- 32.96
- Axiscades Technologies
- 73.64
- 8.67
- 5.06
- 2.68
- Care Ratings
- 39.01
- 6.62
- 14.75
- 32.86
- Sun Pharma Advanced Research Com
- -
- -
- -340.58
- -168.34
- Quess Corp
- 29.25
- 4.11
- 7.16
- 1.15
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 12-May-25
- Audited Results & Final Dividend
- 30-Jan-25
- Quarterly Results
- 23-Oct-24
- Quarterly Results & Interim Dividend
- 07-Aug-24
- Quarterly Results
- 09-May-24
- Audited Results & Final Dividend
- 24-Jan-24
- Quarterly Results
- 31-Oct-23
- Quarterly Results & Interim Dividend
- 09-Aug-23
- Quarterly Results
- 11-May-23
- Audited Results & Final Dividend
- 28-Jan-23
- Quarterly Results & Interim Dividend
- Meeting Date
- Announced on
- Purpose
- 09-Jul-24
- 10-May-24
- AGM
- 28-Jul-23
- 12-May-23
- AGM
- 18-Apr-23
- 16-Mar-23
- POM
- 26-Sept-22
- 29-Jul-22
- AGM
- 25-Mar-22
- 21-Feb-22
- POM
- 14-Sept-21
- 04-Aug-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 12-May-25
- 27-Jun-25
- 27-Jun-25
- 11
- 23-Oct-24
- 05-Nov-24
- 05-Nov-24
- 7
- 10-May-24
- 21-Jun-24
- 21-Jun-24
- 11
- 31-Oct-23
- 10-Nov-23
- 10-Nov-23
- 7
- 12-May-23
- 07-Jul-23
- 07-Jul-23
- 7
- 13-May-23
- 07-Jul-23
- 07-Jul-23
- 8
- 30-Jan-23
- 10-Feb-23
- 10-Feb-23
- 10
- 30-May-22
- 14-Sept-22
- 13-Sept-22
- 10
- 29-Oct-21
- 12-Nov-21
- 11-Nov-21
- 7
- 14-Jun-21
- 07-Sept-21
- 06-Sept-21
- 6


